OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
September 29, 2015
Hovione will double its manufacturing capacity in New Jersey with an expanded facility and a commercial spray dryer designed to handle potent APIs.
The CDMO is striving to become a market leader in the development and manufacturing of antibody-drug conjugates.
September 28, 2015
The agency releases guidance on controlled correspondences related to generic-drug development.
September 25, 2015
There is growing interest in the development of liquid formulations in prefilled syringes and autoinjectors, which offer convenience and ease of administration in a home setting.
September 24, 2015
Cobra Biologics and the University of Manchester announce a collaboration to improve industrial scale-up of mammalian cell bioprocessing.
September 22, 2015
In testifying before Congress on FDA regulation of long-awaited biosimilars, Janet Woodcock emphasized the importance of ensuring that the evaluation of new therapies is based on sound science.
September 21, 2015
IMA Active’s new tablet press machine, Prexima, is designed to deliver higher productivity and efficiency.
September 16, 2015
Nexvet Biopharma, a veterinary biologics developer, secured a dedicated, cGMP biologics manufacturing facility in Tullamore, Ireland, and plans to invest in disposable technology.
September 15, 2015
Manufacturers challenge details in new policies designed to promote access to important therapies.
September 10, 2015
The Krämer KCP10 upward-conveying capsule polisher elevates, polishes, and dedusts capsules.